Journal of Applied Physiology, Vol 66, Issue 5 2136-2144, Copyright © 1989 by American Physiological Society

ARTICLES

Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary edema

P. Bartsch, A. Haeberli, M. Franciolli, E. K. Kruithof and P. W. Straub
Department of Medicine, University of Bern, Switzerland.

To examine whether intravascular coagulation and/or decreased fibrinolysis precedes high-altitude pulmonary edema (HAPE) we examined 25 male mountaineers (median age 40 yr) at low altitude (550 m) and after 6, 18, and 42 h at an altitude of 4,559 m, which was climbed in 24 h. In 14 subjects, 2 of whom showed radiological evidence of HAPE after 42 h, symptoms of acute mountain sickness (AMS) were mild or absent. Eleven subjects suffered from AMS, six of whom developed radiologically documented HAPE after 18 or 42 h. In the absence of AMS there were no significant changes at high altitude, with the exception of a decrease in bleeding time from 246 +/- 18 to 212 +/- 13 (SE) (P less than 0.05). In AMS, partial thromboplastine time decreased from 34.2 +/- 0.8 to 31.1 +/- 0.5 s (P less than 0.001) and factor VIII procoagulant activity and von Willebrand factor antigen were increased by 57 +/- 12 and 70 +/- 13%, respectively (P less than 0.001), whereas there were no significant changes in beta-thromboglobulin (BTG), fibrinopeptide A (FPA), and fibrin fragment B beta 15-42. In subjects with HAPE, BTG, FPA, and B beta 15-42 were normal before and in beginning HAPE. Preceding HAPE, euglobulin clot lysis time declined at high compared with low altitude from 289 +/- 48 to 201 +/- 42 min without venous occlusion (VO) and from 107 +/- 36 to 86 +/- 31 min after VO (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. M. Luks and E. R. Swenson Travel to high altitude with pre-existing lung disease Eur. Respir. J., April 1, 2007; 29(4): 770 - 792. [Abstract] [Full Text] [PDF]

				P. Bartsch How thrombogenic is hypoxia? JAMA, May 17, 2006; 295(19): 2297 - 2299. [Full Text] [PDF]

				T. Lehmann, H. Mairbaurl, B. Pleisch, M. Maggiorini, P. Bartsch, and W. H. Reinhart Platelet count and function at high altitude and in high-altitude pulmonary edema J Appl Physiol, February 1, 2006; 100(2): 690 - 694. [Abstract] [Full Text] [PDF]

				P. Bartsch, H. Mairbaurl, M. Maggiorini, and E. R. Swenson Physiological aspects of high-altitude pulmonary edema J Appl Physiol, March 1, 2005; 98(3): 1101 - 1110. [Abstract] [Full Text] [PDF]

				E. R. Swenson, M. Maggiorini, S. Mongovin, J. S. R. Gibbs, I. Greve, H. Mairbaurl, and P. Bartsch Pathogenesis of High-Altitude Pulmonary Edema: Inflammation Is Not an Etiologic Factor JAMA, May 1, 2002; 287(17): 2228 - 2235. [Abstract] [Full Text] [PDF]

				P. Bartsch, U. Eichenberger, P. E. Ballmer, J. S. R. Gibbs, C. Schirlo, O. Oelz, and E. Mayatepek Urinary Leukotriene E4 Levels Are Not Increased Prior to High-Altitude Pulmonary Edema Chest, May 1, 2000; 117(5): 1393 - 1398. [Abstract] [Full Text] [PDF]

				B. D. Levine, J. H. Zuckerman, and C. R. deFilippi Effect of High-Altitude Exposure in the Elderly : The Tenth Mountain Division Study Circulation, August 19, 1997; 96(4): 1224 - 1232. [Abstract] [Full Text]